Gt Biopharma Share Price Today
(NASDAQ: GTBP)

Name: Gt Biopharma Share Price Today (NASDAQ: GTBP) - Gt Biopharma Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Gt Biopharma share price is $2.27 & ₹194.01 as on 18 Apr 2025, 2.30 'hrs' IST

$2.27

▲

0.02

(0.89%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Gt Biopharma share price in Dollar and Rupees. Guide to invest in Gt Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gt Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Gt Biopharma share price movements

Today's Low: $2.19
Today's High: $2.27
$2.27
3.54%
Downside
Day's Volatility :3.54%
Upside
0.0%
52 Weeks Low: $1.72
52 Weeks High: $10.66
$2.27
24.23%
Downside
52 Weeks Volatility :83.86%
Upside
78.71%

Gt Biopharma (GTBP) Returns

Period	Gt Biopharma Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-1.73%	-2.8%	0.0%
6 Months	-6.2%	-11.0%	0.0%
1 Year	-38.48%	-1.9%	0.0%
3 Years	-96.97%	-1.5%	-12.9%

Gt Biopharma (GTBP) Key Statistics

in dollars & INR

Previous Close	$2.25
Open	$2.25
Today's High	$2.27
Today's Low	$2.1896
Market Capitalization	$5.8M
Today's Volume	$7.0K
52 Week High	$10.6599
52 Week Low	$1.72
Revenue TTM	$0.0
EBITDA	$-6.8M
Earnings Per Share (EPS)	$-6.94
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-453.39%

How to invest in Gt Biopharma Stock (GTBP) from India?

It is very easy for Indian residents to invest directly in Gt Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gt Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gt Biopharma or GTBP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gt Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gt Biopharma shares which would translate to 0.376 fractional shares of Gt Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gt Biopharma, in just a few clicks!

Returns in Gt Biopharma (GTBP) for Indian investors in Rupees

The Gt Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Gt Biopharma investment value today

Current value as on today

₹63,859

Returns

₹36,141

(-36.14%)

Returns from Gt Biopharma Stock

₹38,482 (-38.48%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Gt Biopharma (GTBP)

-66%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Gt Biopharma Stock from India on INDmoney has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Gt Biopharma

DekaBank Deutsche Girozentrale
45.53%
BMO Capital Markets Corp.
1.14%
Bank of Montreal
1.14%
Geode Capital Management, LLC
0.59%
Vanguard Group Inc
0.41%
Wells Fargo & Co
0.39%

Analyst Recommendation on Gt Biopharma

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Gt Biopharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Gt Biopharma Stock (GTBP)

What analysts predicted

Upside of 384.58%

Target:

$11.00

Current:

$2.27

Insights on Gt Biopharma Stock (Ticker Symbol: GTBP)

Price Movement
In the last 3 years, GTBP stock has moved down by -96.9%
GTBP vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 115.1%
GTBP vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 125.8%

Gt Biopharma Technicals Summary

Sell

Neutral

Buy

Gt Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Gt Biopharma (GTBP) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Gt Biopharma Inc	-0.44%	-6.2%	-38.48%	-96.97%	1521.43%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Gt Biopharma Inc	NA	NA	NA	0.0	-4.53	-0.98	NA	-0.75
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Gt Biopharma Inc	Buy	$5.8M	1521.43%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Gt Biopharma

GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. The company develops GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550 which targets B7-H3 on the surface of advanced solid tumors; GTB-7550, a product candidate in development for the treatment of lupus and other autoimmune disorders. GT Biopharma, Inc. entered a master services agreement with Cytovance Biologics, Inc. to perform biologic development and manufacturing services, and to produce and test compounds; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.

Organization	Gt Biopharma
Employees	1
CEO	Mr. Michael Martin Breen L.L.B.
Industry	Pharmaceuticals: Other

Management People of Gt Biopharma

Name	Title
Mr. Michael Martin Breen L.L.B.	Interim CEO & Executive Chairman
Mr. Alan Louis Urban CPA	CFO & Secretary

Important FAQs about investing in GTBP Stock from India :

What is Gt Biopharma share price today?

Gt Biopharma share price today stands at $2.27, Open: $2.25 ; Previous Close: $2.25 ; High: $2.27 ; Low: $2.19 ; 52 Week High: $10.66 ; 52 Week Low: $1.72.

The stock opens at $2.25, after a previous close of $2.25. The stock reached a daily high of $2.27 and a low of $2.19, with a 52-week high of $10.66 and a 52-week low of $1.72.

Can Indians buy Gt Biopharma shares?

Yes, Indians can invest in the Gt Biopharma (GTBP) from India.

With INDmoney, you can buy Gt Biopharma at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Gt Biopharma at zero transaction cost.

How can I buy Gt Biopharma shares from India?

It is very easy to buy Gt Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gt Biopharma (GTBP) be purchased?

Yes, you can buy fractional shares of Gt Biopharma with INDmoney app.

What are the documents required to start investing in Gt Biopharma stocks?

To start investing in Gt Biopharma, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.